The companyâs subsidiary "Eugia Pharma Specialities Ltd has received a 505(b)(2) NDA approval from the US Food Drug Administration (USFDA) for its Cyclophosphamide Injection 500 mg/2.5 mL and 1 g/5 mL vial,â Aurobindo Pharma said in a regulatory filing.from Moneycontrol Business News https://ift.tt/3zz7Rdi
No comments:
Post a Comment